These results suggested methionine/cystine restriction and the silent of SLC43A2 may both block the activation of NFκB signaling pathway, which indicated that SLC43A2 could activate NFκB signaling pathway by regulating cellular methionine metabolism in ESCC. The gene discussed is SLC43A2; the disease is esophageal squamous cell carcinoma.